Patents Assigned to Intendis GmbH
  • Patent number: 8986658
    Abstract: The present invention related to the use of a pharmaceutical composition which is essentially free of pharmaceutically active ingredients for the treatment of human skin, especially in the treatment of rosacea, acne, atopic dermatitis, contact dermatitis, perioral dermatitis, psoriasis or neurodermitis, as well as for prophylactic and/or cosmetic purposes.
    Type: Grant
    Filed: December 27, 2013
    Date of Patent: March 24, 2015
    Assignee: Intendis GmbH
    Inventors: Klaus Graupe, Gerald Stadtler
  • Publication number: 20140200354
    Abstract: The current invention describes novel chiral synthetic routes and intermediates for the manufacture of chiral anti-inflammatory agents of general formula VIII in which at least one of the groups X1, X2, X3 is selected from fluoro, chloro, bromo, hydroxy, methoxy, ethoxy, trifluoromethyl, amino whereas the other groups X1, X2, X3 have the meaning of a hydrogen atom, in which at least one of the groups Z1, Z2, Z3 is selected from —O—, —S—, —N(—CH3)—, whereas the other groups Z1, Z2, Z3 have the meaning of a —CH2— group, and in which Ar is an aromatic group.
    Type: Application
    Filed: March 14, 2014
    Publication date: July 17, 2014
    Applicant: Intendis GmbH
    Inventor: Steffen SCHWEIZER
  • Patent number: 8658138
    Abstract: The present invention related to the use of a pharmaceutical composition which is essentially free of pharmaceutically active ingredients for the treatment of human skin, especially in the treatment of rosacea, acne, atopic dermatitis, contact dermatitis, perioral dermatitis, psoriasis or neurodermitis, as well as for prophylactic and/or cosmetic purposes.
    Type: Grant
    Filed: December 23, 2009
    Date of Patent: February 25, 2014
    Assignee: Intendis GmbH
    Inventors: Klaus Graupe, Gerald Städtler
  • Patent number: 8282909
    Abstract: The present invention provides a formulation which contains a poorly water soluble pharmaceutically active compound at a concentration of 50 mg per 100 g formulation or above. The solubility is achieved by a mixture of solvents as described herein. Moreover the formulation as described herein may be used as a base formulation to generate a cream, an ointment, a spray, a foam or an oleogel.
    Type: Grant
    Filed: July 9, 2008
    Date of Patent: October 9, 2012
    Assignee: Intendis GmbH
    Inventors: Hartwig Steckel, Karin Hoffmann
  • Patent number: 8071796
    Abstract: The current invention describes novel chiral synthetic routes and intermediates for the manufacture of chiral anti-inflammatory agents of general formula VIII in which at least one of the groups X1, X2, X3 is selected from fluoro, chloro, bromo, hydroxy, methoxy, ethoxy, trifluoromethyl, amino whereas the other groups X1, X2, X3 have the meaning of a hydrogen atom, in which at least one of the groups Z1, Z2, Z3 is selected from —O—, —S—, —NH—, —N(—CH3)—, whereas the other groups Z1, Z2, Z3 have the meaning of a —CH2— group, and in which Ar is an aromatic group.
    Type: Grant
    Filed: April 17, 2008
    Date of Patent: December 6, 2011
    Assignee: Intendis GmbH
    Inventors: Steffen Schweizer, Alfred Olbrich
  • Publication number: 20100166891
    Abstract: The invention relates to a novel composition comprising hemp oil for treating topical diseases, in particular the hand-foot syndrome.
    Type: Application
    Filed: December 17, 2009
    Publication date: July 1, 2010
    Applicant: Intendis GmbH
    Inventor: Timm Schmidt
  • Publication number: 20080274517
    Abstract: The current invention describes novel chiral synthetic routes and intermediates for the manufacture of chiral anti-inflammatory agents of general formula VIII in which at least one of the groups X1, X2, X3 is selected from fluoro, chloro, bromo, hydroxy, methoxy, ethoxy, trifluoromethyl, amino whereas the other groups X1, X2, X3 have the meaning of a hydrogen atom, in which at least one of the groups Z1, Z2, Z3 is selected from —O—, —S—, —NH—, —N(—CH3)—, whereas the other groups Z1, Z2, Z3 have the meaning of a —CH2— group, and in which Ar is an aromatic group.
    Type: Application
    Filed: April 17, 2008
    Publication date: November 6, 2008
    Applicant: Intendis GmbH
    Inventor: Steffen SCHWEIZER